流动负债 更改
Alaunos Therapeutics USD 921K 153K 2025-09
Amgen USD 25.49B 3.7B 2025-12
AstraZeneca USD 30.62B 3.44B 2025-12
Baxter International USD 2.97B 805M 2025-12
Biogen USD 3.35B 59.4M 2025-12
Bioline Rx USD 13.67M 1.81M 2025-09
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Celltrion KRW 4.01T 343.96B 2025-09
Corcept Therapeutics USD 166.08M 6.18M 2025-12
Cspc Pharmaceutical CNY 10.18B 65.36M 2025-12
Curis USD 14.08M 5.3M 2025-12
Deva Holding AS TRY 6.43B 1.18B 2023-09
Dianthus Therapeutics USD 30.73M 6.88M 2025-12
Divis Laboratories Ltd INR 17.28B 2.76B 2025-09
Gilead Sciences USD 11.81B 485M 2025-12
GlaxoSmithKline GBP 21.39B 57M 2025-12
Incyte USD 1.52B 176.44M 2025-12
Intrexon USD 23.02M 38K 2024-06
Ionis Pharmaceuticals USD 783M 120.46M 2025-12
J&J USD 54.13B 3.26B 2025-12
Kangmei Pharma CNY 5.81B 57.93M 2025-09
Karyopharm Therapeutics USD 92.06M 4.9M 2025-12
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Laboratorios Farma EUR 199.84M 121.75M 2023-12
Malin Corporation EUR 1000K 500K 2024-12
Medical Developments International AUD 5.56M 2.26M 2025-12
Merck USD 28.63B 2.59B 2025-09
Neuren Pharmaceuticals AUD 4.34M 3.58M 2025-12
Novartis USD 27.28B 4.72B 2025-12
Organigram Holdings CAD 94.05M 32.11M 2025-12
Ovoca Bio EUR 186K 2.26M 2025-06
Pfizer USD 36.6B 1.13B 2025-09
Pharma Mar EUR 93.88M 4.94M 2025-12
PTC Therapeutics USD 968.43M 102.18M 2025-12
Qiagen NV USD 512.14M 461.26M 2025-12
Regeneron Pharmaceuticals USD 4.37B 56.7M 2025-12
Roche Holding CHF 28B 421M 2025-12
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sartorius EUR 1.81B 254.3M 2025-09
Sino Biopharmaceutical CNY 24.85B 5.29B 2025-06
TG Therapeutics USD 153.76M 3.05M 2025-12
Tilray USD 259.32M 8.32M 2025-09
Verastem USD 72.27M 12.56M 2025-12
Zealand Pharma A/S 664.96M 513.61M 2025-12
Zz Pientze Pharmaceu CNY 2.14B 1.06B 2025-09